Addex Therapeutics (ADXN) Stock: Buy, Sell, or Hold?
ADXN - Addex Therapeutics Ltd American Depositary Shares
$3.48
-0.01 (-0.29%)
▼
5d:
-4.66%
30d:
-33.08%
90d:
-49.34%
HOLD
LOW Confidence
Analysis Updated: Sep 14, 2026 12:00 AM ET
Earnings: Oct 05, 2026
19d
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADXN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $3.48, which is considered slightly low relative to its 30-day fair value range of $3.35 to $4.77.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $3.21, while resistance sits at $3.97.
Market Sentiment: ADXN scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+762.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $3.21, while resistance sits at $3.97.
Market Sentiment: ADXN scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $30.00 (+762.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.35 -
$4.77
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 762.1% below Wall St target ($30.00)
- CAUTION: Bottoming setup, but lagging the sector by 34% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.35 -
$4.77
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.21
Resistance Level
$3.97
Current Trend
Strong Downtrend
Technical data as of
Sep 14, 2026
Fundamental Context
Wall Street Target
$30.00
(+762.1%)
Revenue Growth (YoY)
-89.2%
Share & Embed Analysis
Last updated: September 15, 2026 9:10 AM ET
Data refreshes hourly during market hours. Next update: 10:10 AM
Data refreshes hourly during market hours. Next update: 10:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 48 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 57 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 49 HOLD |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 58 HOLD |
